BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, May 10, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 17, 2009
View Archived Issues
Yonsei University scientists disclose novel oncolytic compounds
Read More
Entecavir exhibits superior antiviral activity to adefovir in CHB patients
Read More
Vicriviroc exhibits long-term safety in phase II HIV trials, phase III trials under way
Read More
PEG-Interferon lambda effective in HCV genotype 1 relapsed patients
Read More
Taribavirin has anemia benefits versus ribavirin in HCV patients
Read More
IMO-2125 shows promising anti-HCV activity in preclinical evaluation
Read More
New vanilloid TRPV1 receptor ligands claimed by sanofi-aventis as analgesics
Read More
Protein kinase inhibitors in development at IRM for the treatment of cancer
Read More
Novel antiparkinsonian compounds described by Israeli scientists
Read More
Spherix reports interim results of phase III trial of D-tagatose in diabetes
Read More
FDA approves Lysteda for the treatment of menorrhagia
Read More
Alkermes reports results from phase III naltrexone trial for opioid dependence
Read More
Aegerion reports additional lomitapide phase III data
Read More
Winston Laboratories reports topline results of phase II civamide patch trial
Read More
Esperion Therapeutics initiates phase I ETC-1002 trial in healthy volunteers
Read More
Genzyme receives FDA complete response letter on Lumizyme marketing application
Read More
Eisai launches Lusedra injection for monitored anesthesia care sedation
Read More
Seattle Genetics initiates phase I SGN-75 trial in patients with cancer
Read More
Poniard's phase III trial of picoplatin in lung cancer does not meet primary endpoint
Read More
Brookstone Pharmaceuticals becomes Acella Pharmaceuticals
Read More
Onyx acquires Proteolix
Read More
Sciele Pharma to acquire Addrenex
Read More
SB-939 shows favorable PK, PD and safety in phase I trial in advanced solid tumors
Read More
COMP recommends orphan drug status for Proteo's Elafin in esophagus carcinoma
Read More
GSK and Nabi sign option and licensing agreement for NicVAX nicotine vaccine
Read More